n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide has been researched along with Thromboembolism in 1 studies
N(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide: thrombin inhibitor; RN given refers to parent cpd without isomeric designation
Thromboembolism: Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This review summarizes the discovery and optimization of representative novel oral anticoagulants with the aim to improve selectivity and bioavailability of compounds." | 2.58 | The selectivity and bioavailability improvement of novel oral anticoagulants: An overview. ( Cheng, K; Li, S; Liao, C; Lv, X; Tian, Y; Xiao, X; Xie, Z; Zhan, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xie, Z | 1 |
| Tian, Y | 1 |
| Lv, X | 1 |
| Xiao, X | 1 |
| Zhan, M | 1 |
| Cheng, K | 1 |
| Li, S | 1 |
| Liao, C | 1 |
1 review available for n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide and Thromboembolism
| Article | Year |
|---|---|
The selectivity and bioavailability improvement of novel oral anticoagulants: An overview.
Topics: Administration, Oral; Anticoagulants; Biological Availability; Humans; Thromboembolism | 2018 |